Stereotactic Radiotherapy for the Treatment of Brain Metastases.
- Author:
Dae Yong KIM
1
;
Yong Chan AHN
;
Seung Jae HUH
;
Jung Il LEE
;
Do Hyun NAM
;
Seung Chyul HONG
;
Hyung Jin SHIN
;
Kwan PARK
;
Jong Hyun KIM
Author Information
1. Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Brain metastases;
Stereotactic radiosurgery;
Fractionated stereotactic radiotherapy
- MeSH:
Brain Neoplasms;
Brain Stem;
Brain*;
Humans;
Neoplasm Metastasis*;
Radiosurgery;
Radiotherapy*;
Survival Rate;
Thalamus;
Tumor Burden
- From:Journal of the Korean Cancer Association
2000;32(1):148-155
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the clinical results of stereotactic radiosurgery (SRS) and frac- tionated stereotactic radiotherapy (FSRT) for metastatic brain tumors. MATERIALS AND METHODS: Nineteen patients with brain metastases (34 lesions) were treated with LINAC-based SRS or FSRT with or without whole brain radiotherapy between October 1995 and February 1998. SRS was preferred to FSRT in cases with three or more lesions and poor performance status. FSRT was preferred to SRS in cases with lesions larger than 3 cm and lesions located near or at the eloquent areas such as thalamus, brain stem, and optic apparatus. Single isocenter was used both in SRS and FSRT, and the median peripheral dose in SRS was 15 Gy (range 13~20 Gy), while that in FSRT was 21 Gy (range 15~24 Gy) by 3 Gy per fraction. RESULTS: Local control was achieved in 79% (27/34 treated lesions) and 1-year over- all survival rate was 58% with the median survival of 12 months. Lethal progressive brain metastases, both local and regional, were in four patients (27% of all deaths). No significant differences in local control and survival was observed with histology, age, sex, performance status, tumor volume, number of lesions, or treatment modality. Unacceptable acute or late complications did not occur. CONCLUSION: Stereotactic radiotherapy including SRS and FSRT is effective, non-invasive therapy for brain metastases. This study suggests that stereotactic radiotherapy might be an alternative to surgical resection in selected patients of brain metastases.
